SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Arendt-Nielsen L, Curatolo M, Drewes A. Human experimental pain models in drug development: translational pain research. Curr Opin Investig Drugs 2007; 8: 4153.
  • 2
    Staahl C, Olesen AE, Andresen T, Arendt-Nielsen L, Drewes AM. Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review. Br J Clin Pharmacol 2009; 68: 32241.
  • 3
    Staahl C, Olesen AE, Andresen T, Arendt-Nielsen L, Drewes AM. Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review. Br J Clin Pharmacol 2009; 68: 14968.
  • 4
    Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 81624.
  • 5
    Lynn B. Capsaicin: actions on the nociceptive C-fibres and therapeutic potential. Pain 1990; 41: 619.
  • 6
    Woolf CJ. Windup and central sensitization are not equivalent. Pain 1996; 66: 1058.
  • 7
    Park KM, Max MB, Robinovitz E, Gracely RH, Bennett GJ. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 1995; 63: 16372.
  • 8
    Simone DA, Baumann TK, LaMotte RH. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989; 38: 99107.
  • 9
    Torebjörk HE, Lundberg LE, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol 1992; 448: 76580.
  • 10
    Campbell JN, Raja SN, Meyer RA, Mackinnon SE. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 1988; 32: 8994.
  • 11
    LaMotte RH, Shain CN, Simone DA, Tsai EF. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol 1999; 66: 190211.
  • 12
    Sang CN, Gracely RH, Max MB, Bennett GJ. Capsaicin-evoked mechanical allodynia and hyperalgesia cross nerve territories. Evidence for a central mechanism. Anesthesiology 1996; 85: 49196.
  • 13
    Ali Z, Meyer RA, Campbell JN. Secondary hyperalgesia to mechanical but not heat stimuli following a capsaicin injection in hairy skin. Pain 1996; 68: 40111.
  • 14
    Raja SN, Campbell JN, Meyer RA. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain 1984; 107: 117988.
  • 15
    Koltzenburg M, Lundberg LE, Torebjörk HE. Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 1992; 51: 20719.
  • 16
    Kalman S, Linderfalk C, Wårdell K, Eintrei C, Lisander B. Differential effect on vasodilation and pain after intradermal capsaicin in humans during decay of intravenous regional anesthesia with mepivacaine. Reg Anesth Pain Med 1998; 23: 4028.
  • 17
    Gazerani P, Anderson OK, Arendt-Nielsen L. Site-specific, dose-dependent, and sex-related responses to the experimental pain model induced by intradermal injection of capsaicin to the foreheads and forearms of healthy humans. J Orofac Pain 2007; 21: 289302.
  • 18
    Gazerani P, Kaeseler A, Arendt-Nielsen L. A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain 2005; 118: 15563.
  • 19
    Gustafsson H, Akesson J, Lau CL, Williams D, Miller L, Yap S, Rolan P. A comparison of two formulations of intradermal capsaicin as models of neuropathic pain in healthy volunteers. Br J Clin Pharmacol 2009; 68: 5117.
  • 20
    Hughes A, Macleod A, Growcott J, Thomas I. Assessment of the reproducibility of intradermal administration of capsaicin as a model for inducing human pain. Pain 2002; 99: 32331.
  • 21
    Liu M, Max MB, Robinovitz E, Gracely RH, Bennett GJ. The human capsaicin model of allodynia and hyperalgesia: sources of variability and methods for reduction. J Pain Symptom Manage 1998; 16: 1020.
  • 22
    Scanlon GC, Wallace MS, Ispirescu JS, Schulteis G. Intradermal capsaicin causes dose-dependent pain, allodynia, and hyperalgesia in humans. J Investig Med 2006; 54: 23844.
  • 23
    Wang H, Bolognese J, Calder N, Baxendale J, Kehler A, Cummings C, Connell J, Herman G. Effects of morphine and pregabalin compared with diphenhydramine hydrochloride and placebo on hyperalgesia and allodynia induced by intradermal capsaicin in healthy male subjects. J Pain 2008; 9: 108895.
  • 24
    Sumikura H, Anderson OK, Drewes AM, Arendt-Nielsen L. Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin. Pain 2003; 105: 28591.
  • 25
    Gottrup H, Juhl G, Kristensen AD, Lai R, Chizh BA, Brown J, Bach FW, Jensen TS. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology 2004; 101: 140008.
  • 26
    Foster DC, Dworkin RH, Wood RW. Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women. Pain 2005; 117: 12836.
  • 27
    Shenker NG, Haigh RC, Mapp PI, Harris N, Blake DR. Contralateral hyperalgesia and allodynia following intradermal capsaicin injection in man. Rheumatology 2008; 47: 141721.
  • 28
    Baron R, Binder A. Wie neuropathisch ist die Lumboischialgie? Orthopade 2004; 33: 56875.
  • 29
    Scholz J, Mannion RJ, Hord DE, Griffin RS, Rawal B, Zheng H, Scoffings D, Phillips A, Guo J, Laing RJC, Abdi S, Decosterd I, Woolf CJ. A novel tool for the assessment of pain: validation in low back pain. PLoS Med 2009; 6: e1000047.
  • 30
    Simone DA, Nolano M, Johnson T, Wendelschafer-Crabb G, Kennedy WR. Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci 1998; 18: 894759.
  • 31
    Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain 2003; 4: 40714.
  • 32
    Andresen T, Staahl C, Oksche A, Mansikka H, Arendt-Nielsen L, Drewes A. Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain. Br J Pharmacol 2010; 10: 14765381.
  • 33
    Kraft B, Frickey NA, Kaufmann RM, Reif M, Frey R, Gustorff B, Kress HG. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers. Anesthesiology 2007; 109: 10110.
  • 34
    Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazaretto D, Bentley H, Gouaux B, Abramson I. ‘Gold standard’ Studies show that inhaled marijuana is medically safe and effective. Anesthesiology 2007; 107: 78596.
  • 35
    Pöyhiä R, Vainio A. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia. Clin J Pain 2006; 22: 326.
  • 36
    Gottrup H, Juhl G, Kristensen AD, Lai R, Chizh BA, Brown J, Bach FW, Jensen TS. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology 2004; 101: 14008.
  • 37
    Wallace MS, Quessy S, Schulteis G. Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model. Pharmacol Biochem Behav 2004; 78: 34955.
  • 38
    Arendt-Nielsen L, Yarnitsky D. Experimental and clinical applications of quantitative sensory tsting applied to skin, muscles and viscera. J Pain 2009; 10: 55672.
  • 39
    Chizh BA, Priestley T, Rowbotham M, Schaffler K. Predicting therapeutic efficacy – Experimental pain in human subjects. Brain Res Rev 2009; 60: 24354.